Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern
By BY KATHERINE J. WU AND KATIE THOMAS via NYT Health https://ift.tt/31lgGsv New York Times Health Clinical Trials, Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), your-feed-healthcare October 14, 2020 at 12:56AM
Leave a Comment